---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015612"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T03:01:03.453513+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# PAVmed shareholders re-elect directors, approve equity plan increase and stock issuance at annual meeting

## Summary
- Re-elected Lishan Aklog (7.15M for, 2.08M withheld) and Michael Glennon (7.22M for, 2.01M withheld) as Class C directors.
- Approved issuance of common stock upon exercise of pre-funded warrants from Feb 2025 private placement (4.65M for, 0.29M against).
- Approved amendment to 2014 equity plan increasing authorized shares by 2.5M, from 2,412,140 to 4,912,140 shares.
- Advisory say-on-pay passed with 7.11M for, 0.38M against; ratification of Marcum LLP as auditor for 2025 passed with 14.22M for.
- Turnout was ~77.2% of outstanding shares entitled to vote (common + preferred as-converted).

## SEC filing metadata
- accession: 0001641172-25-015612
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000164117225015612/0001641172-25-015612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000164117225015612/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015612
- JSON: https://secwatch.observer/filing/0001641172-25-015612.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015612.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.